TEKLA CAPITAL MANAGEMENT LLC – Alnylam Pharmaceuticals, Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$28.66M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +11.53% | 14.8K shares | 9.93M | $200.16 | 143.21K |
| Q2 2022 | share | Decrease | -19.04% | -30.19K shares | -7.17M | $145.85 | 128.41K |
| Q1 2022 | share | Decrease | -16.39% | -31.08K shares | -6.26M | $163.29 | 158.60K |
| Q4 2021 | share | 0.00% | 0 shares | -3.64M | $171.03 | 189.69K | |
| Q3 2021 | share | Increase | +41.04% | 55.2K shares | 13.01M | $188.81 | 189.69K |
| Q2 2021 | share | Decrease | -13.17% | -20.40K shares | 929K | $169.52 | 134.49K |
| Q1 2021 | share | Decrease | -11.43% | -19.99K shares | -860K | $141.19 | 154.90K |
| Q4 2020 | share | 0.00% | 0 shares | -2.73M | $129.97 | 174.89K | |
| Q3 2020 | share | Increase | +38.95% | 49.02K shares | 6.82M | $145.6 | 174.89K |
| Q2 2020 | share | Decrease | -8.54% | -11.75K shares | 3.66M | $148.11 | 125.86K |
| Q1 2020 | share | Decrease | -4.30% | -6.17K shares | -1.58M | $108.85 | 137.61K |
| Q4 2019 | share | Decrease | -13.52% | -22.48K shares | 3.18M | $115.17 | 143.79K |
| Q3 2019 | share | Increase | +3.04% | 4.90K shares | 1.66M | $80.42 | 166.27K |
| Q2 2019 | share | Increase | +20.92% | 27.91K shares | -763K | $72.56 | 161.37K |
| Q1 2019 | share | Increase | +5.77% | 7.28K shares | 3.27M | $93.45 | 133.45K |
| Q4 2018 | share | 0.00% | 0 shares | -1.84M | $72.91 | 126.17K | |
| Q3 2018 | share | Decrease | -3.22% | -4.2K shares | -1.79M | $87.52 | 126.17K |
| Q2 2018 | share | 0.00% | 0 shares | -2.68M | $98.49 | 130.37K | |
| Q1 2018 | share | Increase | +13.40% | 15.41K shares | 922K | $119.1 | 130.37K |
| Q4 2017 | share | 0.00% | 0 shares | 1.09M | $127.05 | 114.96K | |
| Q3 2017 | share | 0.00% | 0 shares | 4.33M | $117.49 | 114.96K | |
| Q2 2017 | share | Decrease | -52.88% | -129.02K shares | -3.33M | $79.76 | 114.96K |
| Q1 2017 | share | 0.00% | 0 shares | 3.37M | $51.25 | 243.99K | |
| Q4 2016 | share | 0.00% | 0 shares | -7.40M | $37.44 | 243.99K | |
| Q3 2016 | share | 0.00% | 0 shares | 2.99M | $67.78 | 243.99K | |
| Q2 2016 | share | Increase | +77.46% | 106.5K shares | 4.90M | $55.49 | 243.99K |
| Q1 2016 | share | 0.00% | 0 shares | -4.31M | $62.77 | 137.49K |